High levels of self-reported prescription opioid use by HIV-positive individuals

References

• Azar, P., Wood, E., Nguyen, P., Luma, M., Montaner, J., Kerr, T., & Milloy, M. J. (2015). Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: A longitudinal analysis. BMC Infectious Diseases, 15, 193. doi:10.1186/s12879-015-0913-0
   PubMed Web of Science ®Google Scholar
• Banerjee, A., Strazza, M., Wigdahl, B., Pirrone, V., Meucci, O., & Nonnemacher, M. R. (2011). Role of mu-opioids as cofactors in human immunodeficiency virus type 1 disease progression and neuropathogenesis. Journal of Neurovirology, 17(4), 291–302. doi: 10.1007/s13365-011-0037-2
   PubMed Web of Science ®Google Scholar
• Benotsch, E. G., Martin, A. M., Koester, S., Cejka, A., & Luckman, D. (2011, January 1). Nonmedical use of prescription drugs and HIV risk behavior in gay and bisexual men. Sexually Transmitted Diseases, 38(2), 105–110. doi: 10.1097/OLQ.0b013e3181f0bc4b
   PubMed Web of Science ®Google Scholar
• Boone, M. R., Cook, S. H., & Wilson, P. (2013, June 1). Substance use and sexual risk behavior in HIV-positive men who have sex with men: An episode-level analysis. AIDS and Behavior, 17(5), 1883–1887. doi: 10.1007/s10461-012-0167-4
   PubMed Web of Science ®Google Scholar
• Carey, J. W., Mejia, R., Bingham, T., Ciesielski, C., Gelaude, D., Herbst, J. H., … Stall, R. (2009, January 1). Drug use, high-risk sex behaviors, and increased risk for recent HIV infection among men who have sex with men in Chicago and Los Angeles. AIDS and Behavior, 13(6), 1084–1096. doi: 10.1007/s10461-008-9403-3
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2011). Vital signs: Overdoses of prescription opioid pain relievers—United States, 1999–2008. MMWR Morbidity and Mortality Weekly Report, 60, 1487–1492.
   Google Scholar
• Celentano, D. D., Latimore, A. D., & Mehta, S. H. (2008, November 1). Variations in sexual risks in drug users: Emerging themes in a behavioral context. Current HIV/AIDS Reports, 5(4), 212–218. doi: 10.1007/s11904-008-0030-4
   PubMedGoogle Scholar
• Colfax, G., & Shoptaw, S. (2005, December 1). The methamphetamine epidemic: Implications for HIV prevention and treatment. Current HIV/AIDS Reports, 2(4), 194–199. doi: 10.1007/s11904-005-0016-4
   PubMedGoogle Scholar
• Frenk, S. M., Porter, K. S., & Paulozzi, L. J. (2015). Prescription opioid analgesic use among adults: United States, 1999–2012. NCHS Data Brief, 189, 1–8.
   PubMedGoogle Scholar
• Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., … Longshore, D. (2007, March 1). Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior, 11(2), 185–194. doi: 10.1007/s10461-006-9152-0
   PubMed Web of Science ®Google Scholar
• Horvath, K. J., Carrico, A. W., Simoni, J., Boyer, E. W., Amico, K. R., & Petroll, A. E. (2013, January 1). Engagement in HIV medical care and technology use among stimulant-using and nonstimulant-using men who have sex with men. Aids Research and Treatment, 2013. doi:10.1155/2013/121352
   PubMedGoogle Scholar
• Jeevanjee, S., Penko, J., Guzman, D., Miaskowski, C., Bangsberg, D. R., & Kushel, M. B. (2014, July 1). Opioid analgesic misuse is associated with incomplete antiretroviral adherence in a cohort of HIV-infected indigent adults in San Francisco. AIDS and Behavior, 18(7), 1352–1358. doi: 10.1007/s10461-013-0619-5
   PubMed Web of Science ®Google Scholar
• Johnston, L. D., O’Malley, P. M., Bachman, & Schulenberg, J. E. (2010). Monitoring the future: National survey results on drug use, 1975–2009. Volume I: Secondary school students (NIH publication no. 10-7584). Bathesda, MD: National Institute on Drug Abuse.
   Google Scholar
• Kapadia, F., Vlahov, D., Donahoe, R. M., & Friedland, G. (2005, January 1). The role of substance abuse in HIV disease progression: Reconciling differences from laboratory and epidemiologic investigations. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 41(7), 1027–1034. doi: 10.1086/433175
   PubMed Web of Science ®Google Scholar
• Kelly, B. C., & Parsons, J. T. (2010, April 1). Prevalence and predictors of non-medical prescription drug use among men who have sex with men. Addictive Behaviors, 35(4), 312–317. doi: 10.1016/j.addbeh.2009.11.002
   PubMed Web of Science ®Google Scholar
• Liverpool Drug Interactions Group, University of Liverpool. (2015). Drug interaction charts. Retrieved from www.hiv-druginteractions.org
   Google Scholar
• Malta, M., Strathdee, S. A., Magnanini, M. M., & Bastos, F. I. (2008). Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review. Addiction, 103(8), 1242–57. doi: 10.1111/j.1360-0443.2008.02269.x
   PubMed Web of Science ®Google Scholar
• McCabe, S. E., Boyd, C. J., & Teter, C. J. (2009, January 1). Subtypes of nonmedical prescription drug misuse. Drug and Alcohol Dependence, 102(1–3), 63–70. doi: 10.1016/j.drugalcdep.2009.01.007
   PubMed Web of Science ®Google Scholar
• McCauley, J. L., Danielson, C. K., Amstadter, A. B., Ruggiero, K. J., Resnick, H. S., Hanson, R. F., … Kilpatrick, D. G. (2010, January 1). The role of traumatic event history in non-medical use of prescription drugs among a nationally representative sample of US adolescents. Journal of Child Psychology and Psychiatry, 51(1), 84–93. doi: 10.1111/j.1469-7610.2009.02134.x
   PubMed Web of Science ®Google Scholar
• Merlin, J. S., Walcott, M., Ritchie, C., Herbey, I., Kertesz, S. G., Chamot, E., Saag, M., … Turan, J. M. (2014, November 1). ‘Two pains together’: Patient perspectives on psychological aspects of chronic pain while living with HIV. PLoS One, 9, 11. doi: 10.1371/journal.pone.0111765
   Web of Science ®Google Scholar
• Muhuri, P. K., Gfroerer, J. C., & Davies, M. C. (2013). Associations of nonmedical pain reliever use and initiation of heroin use in the United States (Data review). The Center for Behavioral Health Statistics and Quality.
   Google Scholar
• Nieminen, T. H., Hagelberg, N. M., Saari, T. I., Neuvonen, M., Neuvonen, P. J., Laine, K., & Olkkola, K. T. (2010, January 1). Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir. European Journal of Clinical Pharmacology, 66(10), 977–985. doi: 10.1007/s00228-010-0879-1
   PubMed Web of Science ®Google Scholar
• Prottengeier, J., Koutsilieri, E., & Scheller, C. (2014, January 1). The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts. Aids Research and Therapy, 11, 17. doi:10.1186/1742-6405-11-17
   PubMed Web of Science ®Google Scholar
• Surratt, H. L., Kurtz, S. P., Levi-Minzi, M. A., Cicero, T. J., Tsuyuki, K., & O'Grady, C. L. (2015). Pain treatment and antiretroviral medication adherence among vulnerable HIV-positive patients. AIDS Patient Care and STDs, 29(4), 186–192. doi: 10.1089/apc.2014.0104
   PubMed Web of Science ®Google Scholar
• Vijayaraghavan, M., Freitas, D., Bangsberg, D. R., Miaskowski, C., & Kushel, M. B. (2014, January 1). Non-medical use of non-opioid psychotherapeutic medications in a community-based cohort of HIV-infected indigent adults. Drug and Alcohol Dependence, 143, 263–267. doi: 10.1016/j.drugalcdep.2014.06.044
   PubMed Web of Science ®Google Scholar
• Weisberg, D. F., Gordon, K. S., Barry, D. T., Becker, W. C., Crystal, S., Edelman, E. J., … Fiellin, D. A. (2015, June 1). Long-term prescription of opioids and/or benzodiazepines and mortality among HIV-infected and uninfected patients. Jaids Journal of Acquired Immune Deficiency Syndromes, 69(2), 223–233. doi: 10.1097/QAI.0000000000000591
   PubMed Web of Science ®Google Scholar